Finecure Pharmaceuticals Ltd Revenue and Competitors
Employee Data
- Finecure Pharmaceuticals Ltd has 328 Employees.
- Finecure Pharmaceuticals Ltd grew their employee count by 16% last year.
Finecure Pharmaceuticals Ltd's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Officer Human Resources | Reveal Email/Phone |
2 | Trainee officer - Quality | Reveal Email/Phone |
3 | Finecure Pharmaceutical Ltd - QA Sr. Officer | Reveal Email/Phone |
4 | Quality Control Officer | Reveal Email/Phone |
5 | Production Officer | Reveal Email/Phone |
6 | Junior Officer QA | Reveal Email/Phone |
7 | Junior officer as Production planning and material control | Reveal Email/Phone |
8 | Marketing Director | Reveal Email/Phone |
9 | Manager Contract Manufacturing | Reveal Email/Phone |
What Is Finecure Pharmaceuticals Ltd?
Finecure Pharmaceuticals Limited is leading manufacturers and marketers of Pharmaceutical formulations and Nutraceuticals in several therapeutic segments in dosage forms of Tablets, Capsules, Oral Liquids, Dry Syrup, Powders, Injections, Sachet and Effervescent. The company is WHO GMP certified and also certified for ISO 9001: 2008, ISO 22000: 2005, ISO 14001: 2004, OHSAS 18001: 2007 quality systems towards High Product Quality Assurance, Environment Management System, Occupational Health and safety. Finecure Pharmaceuticals Limited has been awarded several awards and accolades including Arch of Europe Award 2012 ASSOCHAM India Business Excellence Award 2013 ASIA's Most Promising Brand 2014 IPE- Business Excellence Award 2015 Finecure has presence and market in several countries.
keywords:N/A
N/A
Total Funding
328
Number of Employees
N/A
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Finecure Pharmaceuticals Ltd News
Finecure Pharmaceuticals Limited Iscon Life Sciences Sunflower Pharmaceutical Group Co.,ltd. Swisse By-health Co.,ltd
Other Companies in Ahmedabad
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $43.1M | 328 | 18% | N/A |
#2 | N/A | 340 | 65% | N/A |
#3 | N/A | 345 | 26% | N/A |
#4 | $28.5M | 351 | 2% | N/A |
#5 | N/A | 356 | 66% | N/A |